Message #36 From:
Stock News Bot Date: December 13, 2006 06:00:00 AM
EVSC News Exercise and Physical Rehabilitation Specialist Joins Endovasc's Board of Directors
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc - (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
companies engaged in the development of innovative cardiovascular and
metabolic drugs as well as nutraceutical supplements, is pleased to
announce that Dale R.Greenwald has joined the Company’s
Board of Directors.
Mr. Greenwald is an exercise physiologist who brings 20 years of
experience in physical therapy and rehabilitation to Endovasc. He is a
Certified Strength and Condition Specialist and a Neuromuscular
Therapist with a degree in Exercise Physiology from the University of
Colorado. Mr. Greenwald is the owner of Active Therapy Professionals,
Inc., a company that specializes in the second-stage rehabilitation of
individuals recovering from injuries. Prior to opening this business in
1989, Mr. Greenwald worked for the University of Colorado Athletics
Department as Assistant Strength and Conditioning Coach.
“Mr. Greenwald has provided Endovasc with
critical assistance in the early development stages of our nutraceutical
product as well as validating patent claims and lobbying for federal
grants for the Liprostin trials. His experience with our company coupled
with his expertise in exercise, rehabilitation and physical therapy will
enable him to provide valuable guidance regarding the company’s
technologies going forward,” commented Dr.
Diane Dottavio, President and Chief Executive Officer of Endovasc, Inc.
Mr. Greenwald is the co-author of “Weight
Training by Design,” a book which provides an
introduction to a groundbreaking new weight training system and
essential information on cardiovascular training, diet, rest,
stretching, and posture. He has presented at national conferences for
organizations such as the American Academy of Osteopathy (AAO) and
National Strength and Conditioning Association (NSCA). He has spoken
about topics such as exercise and second-stage rehabilitation and
posture as it relates to exercise and rehabilitation. Additionally, he
is an inventor and developer of new fitness technologies with a domestic
patent for a rotator cuff rehabilitation machine.
About Endovasc, Inc.
Endovasc, Inc is focused on investing in private companies and
developing and commercializing drug candidates in the areas of
cardiovascular and metabolic medicine. Endovasc is organized as a
business development company, and has invested in the following
subsidiaries: Liprostin Inc., which holds the intellectual property for
a liposomal based treatment to increase circulation and reduce leg pain
in patients suffering from vascular disease; Prostent, Inc., which is
developing a stent coating technology; and Nutraceutical Development
Corporation, which has developed marketed technology to increase muscle
mass.
For more information about Endovasc, please visit www.endovasc.com.
Safe Harbor Statement
The foregoing statements are made under the "Safe Harbor" Private
Securities Litigation Reform Act of 1995 and may contain forward-looking
statements that involve risks and uncertainties that may not be evident
at the time of this release.
